Study Evaluating Impact of the Use of a Computer-based Tool on the Clinical Management of RA Patients
NCT00895050 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 321
Last updated 2011-07-15
Summary
The primary purpose of this study is to evaluate a computer-based tool on the clinical management of patients with rheumatoid arthritis in Spain.
Conditions
Interventions
- OTHER
-
Review of clinical records
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-03-31
- Primary Completion
- 2011-01-31
- Completion
- 2011-01-31
More Related Trials
-
Efficacy and Safety of Subcutaneous Versus Intravenous ACZ885 in Adult Patients With Established Rheumatoid Arthritis
NCT00505089 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550
NCT00414661 ·Status: COMPLETED
-
Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic Treatment
NCT00929357 ·Status: COMPLETED
-
A Study to Evaluate the Use of Apremilast in Patients With Psoriatic Arthritis, Naïve to Biological Treatment
NCT03828045 ·Status: COMPLETED
-
Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) Therapy
NCT00848354 ·Status: COMPLETED ·Phase: PHASE4
-
Study Comparing Etanercept and Methotrexate vs. Methotrexate Alone in Rheumatoid Arthritis
NCT00195494 ·Status: COMPLETED ·Phase: PHASE4
-
Drug Outcome Survey for Biological Treatments in Rheumatoid Arthritis: an Observational Study (Dose)
NCT00794118 ·Status: COMPLETED
-
Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis
NCT00565409 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain
NCT00195377 ·Status: COMPLETED
-
Serum Biomarkers Analysis in Patients With AR Treated With Anti-TMF
NCT02804204 ·Status: UNKNOWN
-
Study to Assess the Management of Synthetic Disease-modifying Antirheumatic Drug (DMARD) at the Onset of Adverse Events, Intolerance or Lack of Efficacy in Rheumatoid Arthritis (RA)
NCT02094326 ·Status: COMPLETED
-
A Study To Investigate Markers Of Inflammation In Rheumatoid Arthritis
NCT00242853 ·Status: COMPLETED
-
A Study To Evaluate The Effect Of CP-690,550 On Measures Of Kidney Function In Patients With Active Rheumatoid Arthritis
NCT01484561 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness in Daily Practice of Different Treatment Strategies for Early Rheumatoid Arthritis.
NCT01172639 ·Status: COMPLETED ·Phase: PHASE4
-
To Estimate the Efficacy of Treatment With TNFi as Monotherapy or Combination Therapy With MTX and Compare and Contrast Efficacy With Tofacitinib as Monotherapy and Combination Therapy in a Real World Setting.
NCT05576051 ·Status: COMPLETED
-
Faecal Analyses in Rheumatoid Arthritis Therapy
NCT03775824 ·Status: COMPLETED
-
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists
NCT00293722 ·Status: COMPLETED
-
Good EULAR Response In Patients With Early Rheumatoid Arthritis
NCT01558089 ·Status: COMPLETED
-
Study Evaluating CCI-779 in Active Rheumatoid Arthritis on Concomitant Methotrexate Therapy
NCT00076206 ·Status: TERMINATED ·Phase: PHASE2
-
Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid Arthritis
NCT00267852 ·Status: COMPLETED
-
An Observational Study to Describe in Routine Clinical Practice the Treatment Patterns of Usage of Biological DMARDs in RA Patients.
NCT02590562 ·Status: COMPLETED
-
Very Early Versus Delayed Etanercept in Patients With RA
NCT02433184 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating the Efficacy of Enbrel (Etanercept) in Subjects in Japan
NCT00503503 ·Status: COMPLETED
-
Rheumatoid Arthritis Synovial Tissue Biopsy Study
NCT07000890 ·Status: COMPLETED ·Phase: NA
-
Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis
NCT00913458 ·Status: COMPLETED ·Phase: PHASE4